Clinical Trial: Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title:
Brief Summary: The objective of the study is to determine whether administration of idebenone can shorten the time to improvement of visual acuity in patients with chronic vision loss due to LHON.
Detailed Summary:
Sponsor: Santhera Pharmaceuticals
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Santhera Pharmaceuticals
Dates:
Date Received: December 16, 2011
Date Started:
Date Completion:
Last Updated: August 21, 2014
Last Verified: August 2014